CA2867994C - Synthetic peptides with a non-narcotic type of analgesic effect - Google Patents

Synthetic peptides with a non-narcotic type of analgesic effect Download PDF

Info

Publication number
CA2867994C
CA2867994C CA2867994A CA2867994A CA2867994C CA 2867994 C CA2867994 C CA 2867994C CA 2867994 A CA2867994 A CA 2867994A CA 2867994 A CA2867994 A CA 2867994A CA 2867994 C CA2867994 C CA 2867994C
Authority
CA
Canada
Prior art keywords
ala
leu
thr
lys
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2867994A
Other languages
English (en)
French (fr)
Other versions
CA2867994A1 (en
Inventor
Gennady Petrovich VLASOV
Arkadiy Mihajlovich KOTIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOTIN Oleg Arkadyevich
Original Assignee
KOTIN Oleg Arkadyevich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOTIN Oleg Arkadyevich filed Critical KOTIN Oleg Arkadyevich
Publication of CA2867994A1 publication Critical patent/CA2867994A1/en
Application granted granted Critical
Publication of CA2867994C publication Critical patent/CA2867994C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA2867994A 2012-03-22 2012-12-07 Synthetic peptides with a non-narcotic type of analgesic effect Active CA2867994C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012110908 2012-03-22
RU2012110908/10A RU2508295C2 (ru) 2012-03-22 2012-03-22 Синтетические пептиды с ненаркотическим типом анальгетического действия
PCT/RU2012/001036 WO2013141750A1 (ru) 2012-03-22 2012-12-07 Синтетические пептиды с ненаркотическим типом анальгетического действия

Publications (2)

Publication Number Publication Date
CA2867994A1 CA2867994A1 (en) 2013-09-26
CA2867994C true CA2867994C (en) 2017-05-16

Family

ID=49223070

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2867994A Active CA2867994C (en) 2012-03-22 2012-12-07 Synthetic peptides with a non-narcotic type of analgesic effect

Country Status (8)

Country Link
US (1) US9260482B2 (https=)
EP (1) EP2848629B1 (https=)
JP (1) JP6118392B2 (https=)
CA (1) CA2867994C (https=)
ES (1) ES2651265T3 (https=)
IN (1) IN2014MN02080A (https=)
RU (1) RU2508295C2 (https=)
WO (1) WO2013141750A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014367781B2 (en) * 2013-12-19 2019-07-04 Eisai R&D Management Co., Ltd. Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
DE102016125645A1 (de) 2016-12-23 2018-06-28 Forschungszentrum Jülich GmbH D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz
RU2651491C1 (ru) 2017-04-07 2018-04-19 Общество с ограниченной ответственностью "Биофармокс" Специфические пептидные ингибиторы клатрина
US20210228677A1 (en) * 2020-01-28 2021-07-29 Pharmbiotech OY Pharmaceutical composition and a method for its manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229658B (it) 1989-04-21 1991-09-06 Eniricerche Spa Analoghi della timopentina retro-inversi ad uno o piu' legami, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche.
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides

Also Published As

Publication number Publication date
EP2848629A4 (en) 2016-03-02
US9260482B2 (en) 2016-02-16
CA2867994A1 (en) 2013-09-26
JP2015512385A (ja) 2015-04-27
JP6118392B2 (ja) 2017-04-19
EP2848629B1 (en) 2017-09-06
WO2013141750A1 (ru) 2013-09-26
RU2508295C2 (ru) 2014-02-27
ES2651265T3 (es) 2018-01-25
US20150073123A1 (en) 2015-03-12
IN2014MN02080A (https=) 2015-08-21
RU2012110908A (ru) 2013-09-27
EP2848629A1 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
CN103649115B (zh) 多肽
US20240293511A1 (en) Hepcidin mimetics for treatment of hereditary hemochromatosis
McElroy et al. Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor
AU2019273132B2 (en) Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
CA2867994C (en) Synthetic peptides with a non-narcotic type of analgesic effect
CA2757874A1 (en) Short-chain peptides as parathyroid hormone (pth) receptor agonist
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
JP6952320B2 (ja) 新規nk3受容体アゴニスト
JP2012500284A (ja) ペプチド性pth受容体アゴニスト
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
AU2003302609A1 (en) Novel chi-conotoxin peptides (-I)
AU718192B2 (en) Peptide derivatives
JP7395149B2 (ja) 神経障害性疼痛における使用のための新規のハイブリッドペプチド模倣物
JP2023529825A (ja) コンフォメーション化された拘束型α-RGIAアナログ
EP2842965A1 (en) Neuromedin U analogs comprising serum albumin binding amino acid residue
JPH06509571A (ja) タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物
WO2025196129A1 (en) Calcitonin gene-related peptide analogues
TW202511281A (zh) 抗病毒多肽類似物
WO2006038206A2 (en) Compounds that modulate trh actions and inhibit the trh-degrading enzyme
RS51950B (sr) Ciklični peptidi antagonisti cxcr4
PL226256B1 (pl) N-podstawione amidy cyklicznych ureidowych analogów dermorfiny, sposoby ich wytwarzania, zastosowanie i środek farmaceutyczny do leczenia i/lub łagodzenia stanów bólowych

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20141125

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241104

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241104

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241104

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251201

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251201